Fernando Gomollón

17.5k citations

210 papers · 7.5k indexed · 3 hit papers · h-index 36

Impact in

Gastroenterology top 0.5%
- Gastroesophageal reflux and treatments
Genetics top 0.2%
- Inflammatory Bowel Disease
- Hemoglobinopathies and Related Disorders

Papers in

Genetics 118
- Inflammatory Bowel Disease 118
Gastroenterology 23

Co-authors: Javier P. Gisbert Silvio Danese Axel Dignaß Simon Travis Gert Van Assche M.À. Gassull Joaquín Hinojosa James O. Lindsay
Journals: Journal of Crohn s and Colitis (20 papers)Gastroenterology (11 papers)Alimentary Pharmacology & Therapeutics (7 papers)Inflammatory Bowel Diseases (7 papers)The American Journal of Gastroenterology (6 papers)
Partner nations: Spain United Kingdom Germany

In The Last Decade

Fernando Gomollón

192 papers receiving 7.3k citations

Hit Papers

align trajectories log scale

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations 2016 · 506 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Journal of Crohn s and Colitis
2014 Journal of Crohn s and Colitis
2010 Journal of Crohn s and Colitis

Peers

Countries citing papers authored by Fernando Gomollón

Since Specialization

Citations

This map shows the geographic impact of Fernando Gomollón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Gomollón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Gomollón more than expected).

Fields of papers citing papers by Fernando Gomollón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Gomollón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Gomollón. The network helps show where Fernando Gomollón may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fernando Gomollón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fernando Gomollón Line = papers co-authored together Fernando Gomollón links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	P808 Use of intestinal ultrasound influences the proportion of suboptimally controlled patients: IBD Podcast Study results Journal of Crohn s and Colitis ·Axel Dignaß, Ferdinando D’Amico, Fernando Gomollón, Giorgos Bamias, Marion P. Emerson, Ana María Vázquez Molini, Christoph Leitner, No Value Skaland, Fernando Magro	2024	2
2	Healthy Lifestyle Is a Protective Factor from Moderate and Severe Relapses and Steroid Use in Inflammatory Bowel Disease: A Prospective Cohort Study Inflammatory Bowel Diseases ·Sandra G. García, Samuel J. Martínez‐Domínguez, Carla J. Gargallo-Puyuelo, Beatriz Gallego, 義弘大沢, 康廣大橋, N. Selvarani, Julia López, Fernando Gomollón	2024	6
3	Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice—Real‐world evidence from the inflammatory bowel diseases‐podcast study United European Gastroenterology Journal ·Ferdinando D’Amico, Fernando Gomollón, Giorgos Bamias, Fernando Magro, Laura E. Targownik, Claudia Leitner, Marion P. Emerson, Ana María Vázquez Molini, Abdulrahman Althagafi, Chidogo R Ajuluchukwu, 郭志翔, Axel Dignaß, (unknown)	2024	10
4	Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction–Associated Steatotic Liver Disease in Lean Individuals Inflammatory Bowel Diseases ·Samuel J. Martínez‐Domínguez, Sandra G. García, Carla J. Gargallo-Puyuelo, Ankhit Pandurangi, Gerald Christianson Bennassar, نايف بن سعيد بن غصن المعمري, M Arroyo, Nicolás Pared, Javier Ampuero, Fernando Gomollón	2023	21
5	NSAIDs, gastrointestinal toxicity and inflammatory bowel disease Gastroenterología y Hepatología (English Edition) ·Gonzalo Hijos, Carlos Sostres, Fernando Gomollón	2022	13
6	Validation of screening criteria for spondyloarthritis in patients with inflammatory bowel disease in routine clinical practice Digestive and Liver Disease ·Fernando Gomollón, Daniel Seoane‐Mato, Miguel Montoro, Xavier Juanola, E. Trujillo, Marta Carrillo‐Palau, Nihar Shah, Tomoyuki Saito, Yolanda Ber, Laura Ramos, Eva Pérez‐Pampín, Rocío Ferreiro‐Iglesias, Lorena Rodríguez‐Alonso, A. Triplett, Jesús Sanz	2022	3
7	Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron Treatment Nutrients ·Guillermo Bastida, Claudia Herrera‐deGuise, Alicia Algaba, Yolanda Ber, YU Zhe, Virginia Robles, Fernando Bermejo, Esteban Sáez‐González, Fernando Gomollón, Pilar Nos	2021	8
8	Idiopathic acute pancreatitis in patients with inflammatory bowel disease: A multicenter cohort study Pancreatology ·Ana García García de Paredes, Enrique Rodríguez de Santiago, Tsuyoshi Sumiya, Marisa Iborra, Alicia Algaba, Dong Yougen, N Llerena, Fernando Gomollón, Manuel Van Domselaar, D. W. Colvin, Raed S. Alkredaa, A. del Val, Fernando Bermejo, Ana Gutiérrez, Jordi Guardiola, Francisco Mesonero, Sabino Riestra, Pilar Nos, Agustı́n Albillos, Antonio López-Sanromán	2020	14
9	The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: Design, monitoring and functions Gastroenterología y Hepatología (English Edition) ·Yamile Zabana, Julián Panés, Pilar Nos, Fernando Gomollón, María Esteve, Valle García-Sánchez, Javier P. Gisbert, Manuel Barreiro‐de Acosta, Eugeni Domènech	2020	7
10	The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases Drugs ·HoUng Kim, Rieke Alten, Luisa Avedano, Axel Dignaß, Fernando Gomollón, Kay Greveson, Jonas Halfvarson, Peter M. Irving, Jørgen Jahnsen, Péter L. Lakatos, Jong Hyuk Lee, Souzi Makri, Ben Parker, Laurent Peyrin‐Biroulet, Stefan Schreiber, Steven Simoens, René Westhovens, Silvio Danese, Ji Hoon Jeong	2020	73
11	<p>Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease – associations with disease phenotype, treatment, and outcome</p> Clinical and Experimental Gastroenterology ·Christine Olbjørn, Milada Cvancarova Småstuen, Espen Thiis‐Evensen, Britt Nakstad, M H Vatn, Jørgen Jahnsen, Petr Ricanek, Simen Vatn, Aina Elisabeth Fossum Moen, Tone M Tannæs, Jonas Christoffer Lindstrøm, Johan D. Söderholm, Jonas Halfvarson, Fernando Gomollón, Christina Casèn, M. K. Karlsson, Rahul Kalla, Alex Adams, Jack Satsangi, Gøri Perminow	2019	65
12	Cost-utility of biological treatment sequences for luminal Crohn’s disease in Europe Expert Review of Pharmacoeconomics & Outcomes Research ·Fanni Rencz, László Gulàcsi, Márta Péntek, K Gecse, Axel Dignaß, Jonas Halfvarson, Fernando Gomollón, Petra Baji, Laurent Peyrin‐Biroulet, Péter L. Lakatos, Valentin Brodszky	2017	23
13	Roundtable on biosimilars with European regulators and medical societies, Brussels, Belgium, 12 January 2016 Generics and Biosimilars Initiative Journal ·Vito Annese, C. Avendaño, Ferdinand C. Breedveld, Niklas Ekman, Thijs J. Giezen, Fernando Gomollón, Pekka Kurki, Tore K Kvien, Andrea Laslop, L. Puig, Robin Thorpe, Martina Weise, Elena Wolff‐Holz	2016	12
14	Development and Validation of the Short Crohnʼs Disease Work Disability Questionnaire Inflammatory Bowel Diseases ·Mercedes Vergara, Beatriz Sicilia, Luís Prieto, Francesc Casellas, Sepideh Pishyar, Fernando Gomollón, Xavier Calvet	2016	7
15	Physician Perspectives on Unresolved Issues in the Management of Ulcerative Colitis Inflammatory Bowel Diseases ·Javier P. Gisbert, Manuel Barreiro‐de Acosta, María Esteve, Valle García–Sánchez, Fernando Gomollón, Jordi Guardiola, Joaquín Hinojosa, María Dolores Martin‐Arranz, Miguel Mínguez, Carlos Taxonera, Isabel Vera	2015	0
16	Infliximab salvage therapy after failure of ciclosporin in corticosteroid‐refractory ulcerative colitis: a multicentre study Alimentary Pharmacology & Therapeutics ·María Chaparro, K. Rust, Eva Iglesias, Julián Panés, Fernándo Muñoz, Guillermo Bastida, Luisa de Castro, Carlos Jiménez, Juan L. Mendoza, Manuel Barreiro‐de Acosta, Afroditi Liarakou, Fernando Gomollón, Xavier Calvet, E. García‐Planella, Min-Chia Chu, Vicent Hernández, Joaquín Hinojosa, Míriam Mañosa, Olga P. Nyssen, Javier P. Gisbert	2011	82
17	Long-term Durability of Infliximab Treatment in Crohn's Disease and Efficacy of Dose “Escalation” in Patients Losing Response Journal of Clinical Gastroenterology ·María Chaparro, Julián Panés, Evi Makri, Míriam Mañosa, María Esteve, Olga Merino, Montserrat Andreu, Ana Gutiérrez, Fernando Gomollón, José Luis Cabriada, Miguel Montoro, Juan L. Mendoza, Pilar Nos, Javier P. Gisbert	2011	92
18	Anemia and inflammatory bowel diseases World Journal of Gastroenterology ·Fernando Gomollón, Javier P. Gisbert	2009	156
19	Uso terapéutico del hierro intravenoso en la patología digestiva Santiago García‐López, Fernando Gomollón, Birgit Blaschon	2004	1
20	Validación de la prueba del aliento con 13C-urea para el diagnóstico inicial de la infección por Helicobacter pylori y la confirmación de su erradicación tras el tratamiento Revista Española de Enfermedades Digestivas ·Javier P. Gisbert, Julio Ducóns, Fernando Gomollón, J. Enrique Domínguez‐Muñoz, Fernando Borda, G Míño, Isabel Jiménez, M.A. Vázquez, Santos Santolaria, Петровић Бранко, Шубарановић Томислав, Милошевић Драган, LU Bing-lin, G. M. Pastor, Antonio Hervás, J M Pajares	2003	6

About Fernando Gomollón

Fernando Gomollón is a scholar working on Genetics, Gastroenterology, Epidemiology, Hematology and Surgery, having authored 210 papers that have together received 7.5k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (118 papers), Microscopic Colitis (101 papers), Helicobacter pylori-related gastroenterology studies (40 papers), Eosinophilic Esophagitis (27 papers), Autoimmune and Inflammatory Disorders (19 papers), Gastric Cancer Management and Outcomes (17 papers), Iron Metabolism and Disorders (16 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). The work is most often cited by research in Gastroenterology (983 citations), Genetics (3.9k citations), Hematology (1.1k citations), Epidemiology (2.9k citations) and Surgery (2.5k citations). Fernando Gomollón has collaborated with scholars based in Spain, United Kingdom and Germany. Frequent co-authors include Javier P. Gisbert, Silvio Danese, Axel Dignaß, Simon Travis, Gert Van Assche, M.À. Gassull, Joaquín Hinojosa, James O. Lindsay, José Luís Mate and Beatriz Sicilia. Their work appears in journals such as Journal of Crohn s and Colitis, Gastroenterology, Alimentary Pharmacology & Therapeutics, Inflammatory Bowel Diseases and The American Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact